Search research articles
Contact Us
Filters
Showing results (81-90 of 143) with videos related to
Page
of 15
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)
|
June 17, 2025
Precise PEGylation Modulates the in Vivo Fate of Peptide Radiopharmaceuticals
Jieting Shen, Siqi Zhang, Xingkai Wang, et al.
Chemmedchem
|
July 26, 2018
Automated Synthesis of (rac)-, (R)-, and (S)-[<sup>18</sup> F]Epifluorohydrin and Their Application for Developing PET Radiotracers Containing a 3-[<sup>18</sup> F]Fluoro-2-hydroxypropyl Moiety
Masayuki Fujinaga, Takayuki Ohkubo, Tomoteru Yamasaki, et al.
Scientific Reports
|
September 11, 2021
Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy
Feng Wu, Yiding Zhang, Wen Cui, et al.
Frontiers in Physiology
|
December 23, 2022
Characterization and diagnostic value of the gut microbial composition in patients with minimal change disease
Yiding Zhang, Yukun Zhou, Wen Cui, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2020
Radiosynthesis of [thiocarbonyl-<sup>11</sup>C]disulfiram and its first PET study in mice
Hideki Ishii, Tomoteru Yamasaki, Joji Yui, et al.
Chemical Society Reviews
|
May 20, 2025
BN-embedded aromatic hydrocarbons: synthesis, functionalization and applications
Qiang Feng, Ying Zhou, Han Xu, et al.
Bioorganic & Medicinal Chemistry
|
January 8, 2016
N-(3,4-Dimethylisoxazol-5-yl)piperazine-4-[4-(2-fluoro-4-[(11)C]methylphenyl)thiazol-2-yl]-1-carboxamide: A promising positron emission tomography ligand for fatty acid amide hydrolase
Yoko Shimoda, Masayuki Fujinaga, Akiko Hatori, et al.
ACS Omega
|
January 17, 2022
Development of a Stable Peptide-Based PET Tracer for Detecting CD133-Expressing Cancer Cells
Kuan Hu, Xiaohui Ma, Lin Xie, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2021
Off-tumor IDO1 target engagements determine the cancer-immune set point and predict the immunotherapeutic efficacy
Lin Xie, Kuan Hu, Yanhong Duo, et al.
ACS Omega
|
March 16, 2026
Dynamic PET Imaging of Elesclomol-Facilitated Copper Delivery in Ischemic Stroke Rats
Xiushuang Yuan, Yiding Zhang, Hongyi Huang, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 143) with videos related to
Sort By:
Page
of 15
Small (Weinheim an Der Bergstrasse, Germany)
|
June 17, 2025
Precise PEGylation Modulates the in Vivo Fate of Peptide Radiopharmaceuticals
Jieting Shen, Siqi Zhang, Xingkai Wang, et al.
Chemmedchem
|
July 26, 2018
Automated Synthesis of (rac)-, (R)-, and (S)-[<sup>18</sup> F]Epifluorohydrin and Their Application for Developing PET Radiotracers Containing a 3-[<sup>18</sup> F]Fluoro-2-hydroxypropyl Moiety
Masayuki Fujinaga, Takayuki Ohkubo, Tomoteru Yamasaki, et al.
Scientific Reports
|
September 11, 2021
Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy
Feng Wu, Yiding Zhang, Wen Cui, et al.
Frontiers in Physiology
|
December 23, 2022
Characterization and diagnostic value of the gut microbial composition in patients with minimal change disease
Yiding Zhang, Yukun Zhou, Wen Cui, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2020
Radiosynthesis of [thiocarbonyl-<sup>11</sup>C]disulfiram and its first PET study in mice
Hideki Ishii, Tomoteru Yamasaki, Joji Yui, et al.
Chemical Society Reviews
|
May 20, 2025
BN-embedded aromatic hydrocarbons: synthesis, functionalization and applications
Qiang Feng, Ying Zhou, Han Xu, et al.
Bioorganic & Medicinal Chemistry
|
January 8, 2016
N-(3,4-Dimethylisoxazol-5-yl)piperazine-4-[4-(2-fluoro-4-[(11)C]methylphenyl)thiazol-2-yl]-1-carboxamide: A promising positron emission tomography ligand for fatty acid amide hydrolase
Yoko Shimoda, Masayuki Fujinaga, Akiko Hatori, et al.
ACS Omega
|
January 17, 2022
Development of a Stable Peptide-Based PET Tracer for Detecting CD133-Expressing Cancer Cells
Kuan Hu, Xiaohui Ma, Lin Xie, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2021
Off-tumor IDO1 target engagements determine the cancer-immune set point and predict the immunotherapeutic efficacy
Lin Xie, Kuan Hu, Yanhong Duo, et al.
ACS Omega
|
March 16, 2026
Dynamic PET Imaging of Elesclomol-Facilitated Copper Delivery in Ischemic Stroke Rats
Xiushuang Yuan, Yiding Zhang, Hongyi Huang, et al.
Page
of 15